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Abstract 
 
Gilles de la Tourette syndrome (GTS) is a childhood-onset neuropsychiatric disorder characterised 
by multiple tics and often associated with behavioural problems. Although there is evidence of 
significantly reduced self-esteem in children and adolescents with GTS, little is known about 
perceived self-concept and its clinical determinants at the transition age between adolescence and 
adulthood. We therefore set out to investigate self-concept in a clinical sample of young patients 
with GTS at this crucial age for personal development. In addition to standard demographic and 
clinical data, we collected self-ratings using a standardised battery of psychometric instruments, as 
well as the Multidimensional Self Concept Scale, a comprehensive questionnaire developed to 
assess self-concept in subjects aged 9 to 19 years, tapping into the social, competence, affect, 
academic, family, and physical domains. We found that patients diagnosed with at least one co-
morbid psychiatric disorder (“GTS-plus” phenotype) reported significantly lower self-concept than 
patients with “pure GTS”, whereas tic-related variables had no impact on self-concept. Anxiety 
symptoms were the main determinants of self-concept, especially trait anxiety with regard to social 
and affective domains. Affective symptoms could also have a negative impact on the physical, 
affective, competence, and social domains of self-concept. Routine screening for these co-morbid 
conditions should be recommended in all patients with GTS seen at transition clinics from 
paediatric to adult care, in order to implement effective treatment interventions whenever possible. 
 
Key words: anxiety; depression; Gilles de la Tourette syndrome; psychiatric co-morbidities; self-
concept; tics. 
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Introduction 
 
Gilles de la Tourette syndrome (GTS) is a childhood-onset neuropsychiatric disorder characterised 
by multiple motor tics plus at least one phonic tic lasting longer than one year (1,2). The average age 
at onset of GTS is around 7 years. The prevalence of GTS in children and adolescents is up to 1%, 
with a male:female ratio of 3-4:1, and a significant reduction of tic severity after adolescence occurs 
in about one third of cases (3,4). Co-morbid psychiatric disorders are reported by the vast majority 
(90%) of patients with GTS, especially attention-deficit hyperactivity disorder (ADHD) and 
obsessive-compulsive disorder (OCD) (2). GTS is also associated with anxiety and affective 
disorders, rage attacks, impulsivity and self-injurious behaviours  (5-7). 
Both tic severity and the presence of psychiatric co-morbidities have been shown to affect patients’ 
health-related quality of life (HR-QoL) (8,9). Tics can impair everyday activities (including job and 
school attendance) and social relationships (10). School functioning is often compromised, especially 
in young patients with co-morbid ADHD (11). Although co-morbid ADHD is known as the main 
cause of social and behavioural difficulties in this patient population (12), affective symptoms have 
consistently been shown to be a major determinant of patients’ wellbeing, as a considerable 
proportion of patients with GTS receive a formal diagnosis of affective disorder, irrespective of 
being diagnosed with ADHD, throughout adolescence (13) and adulthood (14). In particular, there is 
evidence of significantly reduced self-esteem in children and adolescents with GTS. A study by 
Khalifa et al. (15) showed that children with GTS have lower self-perception compared to unaffected 
children. Children with GTS and co-morbid ADHD reported the most significant impairment in the 
physical appearance and social interactions domains. Moreover, poor self-perception in the physical 
appearance domain was found to be associated with earlier age at tic onset. Hesapçıoğlu et al. (16) 
found that female patients younger than 12 years reported lower self-esteem because of their tic 
disorder. Low self-esteem was found to be associated with impairment in all HR-QoL areas, with 
the exception of the academic domain. Although the concepts of self-esteem and self-concept have 
often been used interchangeably, Bracken specifically defined individuals’ self-concepts as “learned 
evaluations of themselves that are based upon their past successes and failures, reinforcement 
histories, and the ways others react to them and interact with them” (17). Self-esteeem and self-
concept are components of self-perception which affect the broader concept of HR-QoL. A study by 
Hanks et al. (18) showed that children and adolescents with a diagnosis of chronic tic disorder have 
reduced levels of self-concept, and identified a negative correlation between self-concept and the 
severity of both tics and co-morbid psychiatric disorders. An association was observed between 
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patient’s self-concept and overall HR-QoL, and it was noted that younger children are less likely to 
exhibit depressive symptoms and tend to report higher self-concepts than adolescents. 
To date, few data are available about the impact of GTS at the transition between adolescence and 
adulthood, a crucial age for the development of self-concept. This is a delicate age for patients with 
tic disorders, as the persistence of symptoms into young adulthood suggests that patients might have 
to face the possibility that their tic disorder persists throughout life as a potentially stigmatising 
condition. Self-concept is particularly important amongst older adolescents with tics, who represent 
a group of young people with GTS at a crucial point in their lives both in terms of adjustment and 
maturation and also in relation to their being at a watershed for the progression or decline of 
symptoms. As tics will remit for many children by late adolescence, those who have tics in late 
adolescence will likely have them for the remainder of their lives.  As self-concept is important for 
long-term functional outcomes (e.g. job, relationships, social factors), the importance of 
understanding factors that contribute to self-concept during this key developmental period cannot 
be underestimated. We set out to investigate self-concept and its determinants in a clinical sample 
of adolescents and young adults with GTS. This was the first study to focus on late adolescence: we 
hypothesised that patients with GTS in this age group experience problems with self-concept related 
to co-morbid conditions (19) and assessed their clinical correlates with a comprehensive battery of 
psychometric instruments. 
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Methods 
 
Participants 
Twenty-two patients (5 girls) with a diagnosis of GTS and a mean age of 18 years (age range 15-19 
years; standard deviation (SD) 1 year), were recruited from the Child and Adolescent 
Neuropsychiatry Outpatient Unit of the Sapienza University in Rome between October 2013 and 
February 2015. The main inclusion criterion was the presence of a validated diagnosis of GTS 
according to current Diagnostic and Statistical Manual for Mental Disorders (DSM) criteria (1). 
Exclusion criteria consisted in the diagnosis of intellectual disability, schizophrenia or other 
psychotic disorders. Suitable participants were recruited from consecutive attenders to our specialist 
clinic and included a mix of newly referred patients and follow-up patients. Each participant and 
his/her parents (for patients younger than 18 years) provided written informed consent before 
enrollment. 
All participants were of white Caucasian ethnic origin with Italian as first language. All but 5 
participants (of which 3 with vocational training diploma) were still in education and living with 
their parents. No patient had educational support needs or physical disorders. Co-morbid diagnoses 
were established through clinical interview incorporating previous diagnostic records. Eight out of 
the 22 participants had no co-morbid psychiatric disorder (“pure” GTS), 8 were diagnosed with 
OCD, 4 with ADHD, and 2 with both OCD and ADHD. The mean age at tic onset was 8 years (SD 
3 years). Five participants had at least one first-degree relative with a tic disorder. Eighteen 
participants were on pharmacotherapy (8 with atypical antipsychotics, 1 with typical antipsychotics, 
2 with antidepressants, 7 with other medications). The duration of pharmacotherapy ranged from 1 
month to 8 years and there were no previous psychological and pharmacological therapeutic 
interventions other than the ones noted on assessment. Mean duration of education was 11 years 
(SD 1 year). 
 
Procedure 
Each participant was systematically assessed within a single session. Specialists in child and 
adolescence psychiatry with extensive experience in tic disorders collected demographic and 
clinical information (ethnicity, first language, gender, age, age at tic onset, family history of tics, 
educational attainment, employment), reviewed inclusion and exclusion criteria, and assessed the 
severity of tics and obsessive-compulsive symptoms using the following two validated rating 
scales: 
- Yale Global Tic Severity Scale (YGTSS) (20) 
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The YGTSS is a clinician-rated instrument that assesses the number, frequency, intensity, 
complexity and interference of motor and phonic tics. YGTSS total tic severity scores range from 0 
(no tics) to 50 (extremely severe tics).  
- Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) (21) 
The Y-BOCS is a clinician-rated instrument that assesses obsessions and compulsions. Each item 
receives a score from 0 to 5 and total scores range from 0 (no obsessive-compulsive symptoms) to 
40 (extremely disabling obsessive-compulsive symptoms).   
 
Each participant was subsequently asked to complete a standardised battery of psychometric 
instruments validated in the Italian language to assess premonitory urges, self-concept, and co-
morbid psychiatric symptoms. The choice of psychometric instruments was guided by the available 
evidence on valid measures in this patient population (22,23). 
- Premonitory Urge for Tics Scale (PUTS) (24) 
The PUTS is a 10-items self-report scale that assesses premonitory urges to tic. Items from 1 to 9 
receive a score ranging from 1 (never) to 4 (always). Higher scores indicate the presence of more 
severe urges.   
- Multidimensional Self Concept Scale (MSCS) (17) 
The MSCS is a 150-item, self-report questionnaire developed to assess self-concept in subjects aged 
9 to 19 years based on Bracken’s multidimensional self-concept model. The MSCS covers 6 
content-dependent self-concept areas, tapping into the social, competence, affect, academic, family, 
and physical domains. Each item is rated on a 4-point scale and higher scores indicate better self-
concept. In addition to general populations, the MSCS has been used in previous studies to evaluate 
self-concept in patients with chronic neuropsychiatric conditions (25,26). 
- Multidimensional Anxiety Scale for Children (MASC) (27) 
The MASC assesses anxiety through a 39-item, self-report measure for use in subjects aged 8 to 19 
years. Items are rated on a 4-point Likert-type scale, and higher scores indicate more severe 
symptoms. 
- State-Trait Anxiety Inventory-form Y (STAI-Y) (28) 
The STAI is a 40-item, self-report questionnaire validated to assess state anxiety (STAI-Y1) and 
trait anxiety (STAI-Y2) in subjects older than 12 years. Items are rated on a 4-point Likert-type 
scale, and higher scores indicate more severe symptoms. 
- Beck Depression Inventory-II (BDI-II) (29) 
The BDI-II is a 21-item, self-report questionnaire validated to assess symptoms of depression in 
subjects older than 13 years. Items are rated on a 4-point Likert-type scale, and higher scores 
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indicate more severe symptoms. Separated scores are provided for cognitive-affective and somatic-
vegetative constructs.   
 
Statistical analysis 
Quantitative data are presented as mean values (± SD), while categorical data are presented as 
absolute and percent frequencies. For the analysis, participants were divided in subgroups based on 
the following grouping variables: (a) gender and other dichotomous variables (e.g. male vs female; 
presence vs absence of family history of tic disorders); (b) tic severity (YGTSS score <10 vs ≥ 10, 
where 10 is the cut-off between minimal and mild tic severity); (c) premonitory urge severity 
(PUTS score <25 vs ≥ 25, where 25 is the cut-off between medium and high intensity of 
premonitory urges for tics); (d) anxiety symptoms (MASC score <50 vs ≥ 50), anxiety state (STAI-
Y1 <75th centile vs ≥ 75th centile) and trait (STAI-Y2 <75th centile vs ≥ 75th centile); (e) affective 
symptoms (BDI-II <90th centile vs ≥ 90th centile); (f) phenotype (“pure” GTS vs “GTS-plus”, i.e. 
GTS with co-morbid psychiatric disorders). Differences in MSCS scores among subgroups were 
assessed using the Mann-Whitney U test and Kruskal-Wallis analysis of variance (for two or more 
than two independent groups, respectively). Finally, multiple linear regression analysis was 
performed to determine the variables significantly and independently affecting MSCS total scores. 
For any dependent variable different models were fitted to data: the adjusted R-squared and Akaike 
Information Criterion (AIC) were computed as measures of model goodness-of-fit. The variance 
inflation factor (VIF) was computed to assess the presence of relevant multicollinearity among 
predictors within a model, with VIF values equal to or greater than 5 suggesting multicollinearity. 
We presented the results of the multiple regression analysis for the model showing the best 
compromise between AIC and VIF values (for both, the lower the value, the better the model). 
Cohen’s f2 values were also calculated to compare the effect sizes of the different predictors within 
each model: f2≥0.02, f2≥0.15, and f2≥0.35 represent small, medium, and large effect sizes, 
respectively. We reported statistically significant regression coefficients, expressed as variation in 
the dependent variable corresponding to a one-unit increase in the predictor score, for any predictor 
alongside the corresponding Cohen’s f2. Statistical analyses were performed using the STATA 
Statistical Software,Version 8.1.  
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Results 
 
In our sample, MSCS total and subscale scores were lower in patients with GTS and co-morbid 
psychiatric disorders compared to patients with “pure” GTS: differences were particularly marked 
in patients who reported more severe anxiety symptoms (as rated by both STAI and MASC scores) 
(Table 1).  
 
[PLEASE INSERT TABLE 1 HERE] 
 
Patients with at least one co-morbid psychiatric diagnosis reported significantly lower self-concept, 
with more pronounced effects on the competence, academic, affect, and social MSCS domains. 
Specifically, the presence of more severe anxiety and affective symptoms was consistently 
associated with significantly lower MSCS social, affect, competence, and physical scores; in 
addition, the presence of more severe state/trait anxiety symptoms were associated with 
significantly lower MSCS family and academic scores. No significant differences in MSCS scores 
were observed between male and female patients, or between patients with lower or higher 
tic/premonitory urge severity. Likewise, neither socio-demographic variables nor treatment 
interventions were associated with decreased self-concept in our clinical sample. 
 
R-squared values resulting from the multiple linear regression analysis on MSCS scores were 
consistently high, ranging from 0.59 to 0.84, with the exception of MSCS family scores (R-squared 
0.34) (Table 2). 
 
[PLEASE INSERT TABLE 2 HERE] 
 
Trait anxiety (STAI-Y2) and, to a lesser extent, depression (BDI-II) centile scores negatively 
affected specific self-concept (MSCS) subscale scores. Specifically, a one-unit increase in the 
STAI-Y2 centile score determined a significant estimated mean decrease of 0.29 in the MSCS total 
score (f2=0.39), 0.37 in the MSCS social score (f2=0.19), 0.27 in the MSCS competence score 
(f2=0.28), 0.22 in the MSCS affect score (f2=0.15), and 0.23 in the MSCS family score (f2=0.21). 
According to Cohen’s f2 values, the effect size was large for the MSCS total score, while it was 
medium for all subscale scores. A one-unit increase in the BDI-II centile score determined a 
significant estimated mean decrease of 0.24 in the MSCS competence score (f2=0.42), and 0.27 in 
the MSCS physical score (f2=0.51), with large effect sizes for both. Cohen’s f2 values indicated a 
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small-to-medium effect size for all variables except MSCS academic scores, where a large effect 
size was observed. 
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Discussion 
 
To the best of our knowledge, this is the first study focusing on self-concept and its clinical 
correlates in patients with GTS at the transition age between adolescence and adulthood. 
Importantly, and differently from previous studies, we recruited patients within a narrow age range 
(15-19 years), with a mean age of 18 years, to ensure that our research findings referred to a patient 
population in the transitory period into adulthood. Interestingly, in our clinical sample, gender, 
socio-demographic variables, types of treatment interventions or tics/tic-related factors were not 
associated with decreased self-concept. However, we found a significantly lower report of self-
concept in patients with the “GTS-plus” phenotype, i.e. patients diagnosed with at least one co-
morbid psychiatric disorder. The presence of psychiatric co-morbidity appeared to affect to a 
greater extent the patients’ perception of their competence and academic skills, as well as their 
social and affective skills. This result is consistent with the findings of previous studies conducted 
on both children/adolescents and adults with GTS. Khalifa et al. (15) found that physical and social 
aspects of self-perception were more strongly affected in young patients with GTS in the presence 
of co-morbid ADHD, whereas Thibert et al. (30) reported a low level of self-concept in adult patients 
with GTS who had co-morbid severe obsessive-compulsive symptoms. 
With regard to the determinants of self-concept in our study sample, we found that the co-
occurrence of anxiety symptoms exerts a negative impact on every self-concept domain assessed by 
the MSCS, and above all on the social and affective domains. Our results showed that self-concept 
could also be influenced by affective symptoms, with possible effects on the physical, affective, 
competence, and social domains. These findings were in line with the results of our multiple 
regression analysis, which showed that STAI-Y2 and BDI-II scores were the strongest predictors of 
MSCS scores. In contrast to state anxiety, trait anxiety (as measured by STAI-Y2 scores) can be 
defined as a relatively enduring disposition to feel stress, worry, and discomfort, and has continuity 
with personality. This is highly relevant, given the possibly increased risk of personality difficulties, 
as well as developmental disorders, in the GTS population (31-33). Interestingly, the findings of the 
recent study by Hesapçıoğlu et al. (16) on a clinical sample of children and adolescents with chronic 
tic disorders also suggested a pivotal role for anxiety and depression in determining self-esteem and 
HR-QOL. A study of youth with chronic tic disorder by Hanks et al. (18) found medium-to-large-
sized associations between patients' self-concept and co-morbid psychiatric disorders (mainly 
severity of ADHD, OCD, and depressive symptoms), patients' self-concepts partially mediated the 
relationship between tic severity and depressive symptom severity, and the interaction between tic 
impairment and reliance on avoidant coping strategies moderated patients' self-concepts. Taken 
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together, the results of these studies highlight the importance of addressing the psychological well-
being of patients with GTS as a way to improve their self-concept throughout childhood, 
adolescence and early adulthood (34,35). Of note, the findings of clinical studies published in the last 
few years suggested the potential efficacy of broader interventions focused on the adverse 
psychosocial consequences of tics (36,37). 
Our study has limitations. Firstly, the relatively small sample size of some of the patient subgroups 
could have affected our findings. This was a consequence of the highly specialist study setting. 
Secondly, referral bias needs to be taken into account as participants were recruited from a tertiary 
referral centre, with focus on patients with more severe tics and may therefore not be representative 
of the community population of people with GTS. Specifically, the population studied was atypical 
as none had evidence of developmental delay or disorder and the rate of psychiatric co-morbidity 
was markedly lower than might have been expected from other studies (2). Thirdly, the use of self-
report questionnaires is subject to social acceptability bias, which might reduce the validity of the 
collected data. Moreover, as in other chronic illnesses, it may be difficult to avoid the possibility 
that the effects of a tic disorder or the side effects of anti-tic medications may lead to misleading 
answers in questions relating to psychiatric symptoms. Likewise, the possibility of a cross-over 
between questions measuring affective symptoms and those relating to self-concept cannot be ruled 
out completely, despite the choice of a self-concept measure which has been previously used in 
clinical populations with neuropsychiatric conditions. This issue might have been particularly 
relevant for the BDI-II items addressing self-dislike and self-criticalness, which are intrinsic to self-
concept. A further limitation of this study is intrinsic to its retrospective approach. Finally, although 
the gender distribution in our sample reflected the male:female ratio observed in the wider GTS 
population, the small number of female patients enrolled in our study might have introduced a bias, 
in consideration of the higher prevalence of anxiety and affective disorders in girls and women. 
In conclusion, our investigation of patient-reported self-concept in patients with GTS at the 
transition between adolescence and young adulthood highlighted the possible roles of anxiety and 
affective symptoms in influencing the psychological well-being of this patient population. Further 
research is needed to replicate these preliminary findings in larger samples both from specialist 
clinics and in the community. Self-concept and psychiatric health may have an important impact 
upon the process of adjustment to a chronic disorder that may endure into adulthood. Well adjusted 
young people entering adult life with GTS may enter a virtuous cycle in which their capacity to live 
with their tics both reduces their risk of psychiatric decompensation and cuts their need for on-
going treatment, with all its attendant risks. Since effective behavioural and pharmacological 
interventions are currently available for both anxiety and affective disorders, routine screening for 
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these co-morbid conditions should be recommended in all patients with GTS seen at transition 
clinics from paediatric to adult care. Finally, should our findings be confirmed by the results of 
future studies, novel treatment approaches might need to be implemented, as the efficacy of 
traditional interventions in trait anxiety may be less reliable. 
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Table 1. Self-concept ratings (mean values ± SD) in patients with Gilles de la Tourette syndrome grouped by 
clinical variables.  
 
Table 2. Results of multiple linear regression analysis of clinical determinants of self-concept in patients with 
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Table 1. Self-concept ratings (mean values ± SD) in patients with Gilles de la Tourette syndrome grouped by clinical variables.  
 
 MSCS social MSCS competence MSCS affect MSCS academic MSCS family MSCS physical MSCS total 
BDI-II p 0.0428 0.0322 0.0157 0.1103 1.0000 0.0090 0.0671 
 Neg n=15 104.33 ± 18.36 101.87 ± 18.22 99.53 ± 13.79 93.67 ± 22.00 103.20 ± 12.29 101.00 ± 11.23 100.47 ± 16.62 
 Pos n=6   84.00 ± 19.87   81.83 ± 13.11 80.50 ± 9.73 78.83 ± 10.48 101.83 ± 7.83 82.83 ± 8.57   82.83 ± 12.17 
MASC                    p 0.0020 0.0894 0.0226 0.4175 0.0965 0.0107 0.0086 
 Neg n=12 108.83 ± 14.47 102.50 ± 19.74 99.92 ± 14.53 92.42 ± 23.93 105.50 ± 8.90 102.00 ± 11.20 102.42 ± 15.13 
 Pos n=8   80.63 ± 16.69   85.75 ± 14.84 83.75 ± 11.57 83.38 ± 14.20     96.63 ± 11.15   85.88 ± 11.27   83.25 ± 14.46 
CO-MORB              p 0.0224 0.0073 0.0124 0.0082 0.0593 0.2043 0.0137 
 Neg n=8 111.88 ± 16.91 109.75 ± 16.08 105.38 ± 13.20 105.38 ± 17.71 109.75 ± 11.65 101.13 ± 10.70 108.00 ± 15.48 
 Pos n=13   90.31 ± 18.63   87.77 ± 15.87   87.15 ± 12.34   79.62 ± 15.24 98.54 ± 8.45   92.54 ± 14.08   87.69 ± 13.60 
PUTS                     p 0.4254 0.0886 0.2177 0.0758 0.7168 0.1277 0.1575 
 Neg n=13 101.31 ± 22.44 101.85 ± 20.01 97.77 ± 16.48 96.54 ± 18.59 102.69 ± 12.73 99.85 ± 11.56 99.92 ± 18.22 
 Pos n=8   94.00 ± 17.56   86.88 ± 13.67 88.13 ± 11.78 77.88 ± 18.50 103.00 ± 8.32 89.25 ± 14.07 88.13 ± 13.44 
STAI-Y1                   p 0.0015 0.0049 0.0062 0.0432 0.0192 0.0807 0.0026 
 Neg n=13 109.30 ± 15.79 105.77 ± 16.84 101.54 ± 14.05 97.46 ± 18.83 107.15 ± 11.36 100.69 ± 11.97 104.38 ± 14.87 
 Pos n=7   78.00 ± 12.94   80.43 ± 10.47 80.71 ± 7.52 75.14 ± 16.96 95.43 ± 6.19   87.71 ± 12.98 79.43 ± 8.48 
STAI-Y2                   p 0.0073 0.0015 0.0093 0.0208 0.0430 0.0207 0.0017 
 Neg n=14 106.86 ± 17.75 105.36 ± 16.11 100.36 ± 14.46 97.36 ± 17.71 106.29 ± 10.52 101.26 ± 10.19 103.57 ± 14.46 
 Pos n=6   78.50 ± 14.01 77.17 ± 7.36 80.00 ± 6.66 71.67 ± 16.72 95.50 ± 9.77   84.17 ± 13.53 77.17 ± 7.36 
 
Statistically significant values (p≤0.05; Mann-Whitney U test) shown in bold. 
 
Abbreviations. MSCS, Multidimensional Self Concept Scale; BDI-II, Beck Depression Inventory-II; MASC, Multidimensional Anxiety Scale for Children; CO-MORB, presence of at 
least one co-morbid psychiatric disorder (“GTS-plus”); PUTS, Premonitory Urge for Tics Scale; STAI-Y1, State-Trait Anxiety Inventory-State Anxiety; STAI-Y2, State-Trait Anxiety 
Inventory-Trait Anxiety.  
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Table 2. Results of multiple linear regression analysis of clinical determinanats of self-concept in patients with Gilles de la Tourette syndrome. 
 
 OCD  ADHD  BDI-II  STAI-Y2  MASC  Adj R
2
 AIC 
 coeff 95% CI coeff 95% CI coeff 95% CI coeff 95% CI coeff 95% CI   
  Cohen’s f2  Cohen’s f2  Cohen’s f2  Cohen’s 
f2 
 Cohen’s f2   
MSCS social -0.99 -15.7 - 13.7 -9.16 -24.2 - 5.8 0.06 -0.28 - 0.41 -0.37 -0.68 - -0.05 -0.41 -1.13 - 0.31 0.66 154.4 
  0.002  0.134  0.012  0.598  0.181   
MSCS competence -2.89 -12.3 - 6.5 -8.09 -17.7 - 1.51 -0.24 -0.46 - -0.02 -0.27 -0.48 - -0.07 -0.03 -0.49 - 0.44 0.84 137.4 
  0.033  0.254  0.409  0.618  0.024   
MSCS affect -1.49 -11.4 - 8.4 -2.47 -12.6 - 7.6 -0.21 -0.44 - 0.02 -0.22 -0.43 - -0.01 0.02 -0.47 - 0.50 0.72 139.3 
  0.008  0.021  0.291  0.449  0.147   
MSCS academic -14.95 -29.1 - -0.84 -11.61 -26.0 - 2.76 -0.27 -0.60 - 0.07 -0.19 -0.49 - 0.11 0.20 -0.50 - 0.89 0.69 152.7 
  0.403  0.234  0.232  0.353  0.023   
MSCS family -5.25 -15.7 - 5.2 -5.28 -15.9 - 5.4 0.07 -0.18 - 0.31 -0.23 -0.45 - -0.01 0.19 -0.32 - 0.70 0.34 141.4 
  0.090  0.088  0.025  0.389  0.039   
MSCS physical 1.87 -8.7 - 12.4 6.79 -3.91 - 17.5 -0.27 -0.52 - -0.02 -0.07 -0.29 - 0.15 -0.18 -0.70 - 0.33 0.59 141.6 
  0.011  0.145  0.433  0.046  0.142   
MSCS total -5.09 -14.0 - 3.79 -5.25 -14.3 - 3.80 -0.14 -0.35 - 0.07 -0.29 -0.48 - -0.10 -0.02 -0.45 - 0.42 0.82 135.2 
  0.118  0.121  0.163  0.987  0.125   
 
Maximum Variance Inflation Factor for the regression model = 3.67; statistically significant values (p≤0.05; multiple linear regression analysis) shown in bold. 
 
Abbreviations. OCD, obsessive-compulsive disorder; ADHD, attention-deficit and hyperactivity disorder; BDI-II, Beck Depression Inventory-II; STAI-Y2, State-Trait Anxiety 
Inventory-Trait Anxiety; MASC, Multidimensional Anxiety Scale for Children; MSCS, Multidimensional Self Concept Scale; Adj R
2
 = adjusted R
2
; AIC = Akaike Information 
Criterion; coeff = coefficient of the multiple linear regression model; 95% CI = 95% Confidence Interval; Cohen’s f2 = effect size for multiple regression.
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Highlights 
 
 
Gilles de la Tourette syndrome (GTS) has an impact on quality of life and self-esteem 
 
This was the first study to investigate self-concept in GTS in late adolescence 
 
Lower self-concept was associated with the presence of comorbid psychiatric disorders 
 
Trait anxiety symptoms were the main determinants of self-concept in our sample 
 
 
